Pieris Pharmaceuticals Inc (PIRS)
10.15
+0.36
(+3.70%)
USD |
NASDAQ |
May 31, 16:00
10.42
+0.27
(+2.66%)
After-Hours: 20:00
Pieris Pharmaceuticals Enterprise Value: -5.684M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -5.684M |
| May 30, 2024 | -6.162M |
| May 29, 2024 | -6.410M |
| May 28, 2024 | -6.212M |
| May 24, 2024 | -5.248M |
| May 23, 2024 | -5.235M |
| May 22, 2024 | -4.580M |
| May 21, 2024 | -4.324M |
| May 20, 2024 | -4.324M |
| May 17, 2024 | -4.601M |
| May 16, 2024 | -4.232M |
| May 15, 2024 | -4.073M |
| May 14, 2024 | -4.271M |
| May 13, 2024 | -4.126M |
| May 10, 2024 | -4.364M |
| May 09, 2024 | -4.351M |
| May 08, 2024 | -5.307M |
| May 07, 2024 | -5.431M |
| May 06, 2024 | -5.406M |
| May 03, 2024 | -5.381M |
| May 02, 2024 | -5.184M |
| May 01, 2024 | -4.639M |
| April 30, 2024 | -4.602M |
| April 29, 2024 | -4.602M |
| April 26, 2024 | -4.590M |
| Date | Value |
|---|---|
| April 25, 2024 | -4.738M |
| April 24, 2024 | -4.330M |
| April 23, 2024 | -4.244M |
| April 22, 2024 | -4.630M |
| April 19, 2024 | -4.738M |
| April 18, 2024 | -3.724M |
| April 17, 2024 | -3.541M |
| April 16, 2024 | -2.858M |
| April 15, 2024 | -2.265M |
| April 12, 2024 | -2.094M |
| April 11, 2024 | -1.632M |
| April 10, 2024 | -1.543M |
| April 09, 2024 | -1.097M |
| April 08, 2024 | -1.958M |
| April 05, 2024 | -2.087M |
| April 04, 2024 | -2.116M |
| April 03, 2024 | -1.850M |
| April 02, 2024 | -1.473M |
| April 01, 2024 | -0.583M |
| March 31, 2024 | -0.9589M |
| March 28, 2024 | -8.241M |
| March 27, 2024 | -7.202M |
| March 26, 2024 | -7.766M |
| March 25, 2024 | -8.389M |
| March 22, 2024 | -6.579M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.52M
Minimum
Jun 30 2023
271.17M
Maximum
Sep 17 2021
64.57M
Average
66.79M
Median
Nov 04 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.892M |
| Revenue (Quarterly) | 0.053M |
| Total Expenses (Quarterly) | 5.356M |
| EPS Diluted (Quarterly) | -3.95 |
| Profit Margin (Quarterly) | -9.23K% |
| Earnings Yield | -117.7% |
| Normalized Earnings Yield | -6.800 |